Abraxane is administered intravenously, usually over a period of 30 minutes. The dosage and frequency depend on the type of cancer being treated and the patient's overall health. Unlike traditional paclitaxel, Abraxane does not require premedication with steroids or antihistamines, making the treatment process more convenient for patients.
